Peter D. Cole
Department of Pediatrics
The Cancer Institute of New Jersey/Robert Wood Johnson University Hospital
195 Little Albany Street
New Brunswick
USA
Name/email consistency: high
- Pharmacodynamic properties of methotrexate and Aminotrexate during weekly therapy. Cole, P.D., Zebala, J.A., Alcaraz, M.J., Smith, A.K., Tan, J., Kamen, B.A. Cancer Chemother. Pharmacol. (2006)
- Delayed neurotoxicity associated with therapy for children with acute lymphoblastic leukemia. Cole, P.D., Kamen, B.A. Ment. Retard. Dev. Disabil. Res. Rev (2006)
- Phase II trial of oral aminopterin for adults and children with refractory acute leukemia. Cole, P.D., Drachtman, R.A., Smith, A.K., Cate, S., Larson, R.A., Hawkins, D.S., Holcenberg, J., Kelly, K., Kamen, B.A. Clin. Cancer Res. (2005)
- "Beriberi" interesting!. Cole, P.D., Kamen, B.A. J. Pediatr. Hematol. Oncol. (2003)
- Osteosarcoma cells, resistant to methotrexate due to nucleoside and nucleobase salvage, are sensitive to nucleoside analogs. Cole, P.D., Smith, A.K., Kamen, B.A. Cancer Chemother. Pharmacol. (2002)
- Effects of overexpression of gamma-Glutamyl hydrolase on methotrexate metabolism and resistance. Cole, P.D., Kamen, B.A., Gorlick, R., Banerjee, D., Smith, A.K., Magill, E., Bertino, J.R. Cancer Res. (2001)
- Benign outcome of RSV infection in children with cancer. Cole, P.D., Suh, J.S., Onel, K., Stiles, J., Armstrong, D., Dunkel, I.J. Med. Pediatr. Oncol. (2001)